Article
Non-coding single nucleotide variants affecting estrogen receptor binding and activity.
Genome medicine - 13 Dec 2016
Bahreini Amir, Levine Kevin, Santana-Santos Lucas, Benos Panayiotis V, Wang Peilu, Andersen Courtney, Oesterreich Steffi, Lee Adrian V
Abstract excerpt
BACKGROUND: Estrogen receptor (ER) activity is critical for the development and progression of the majority of breast cancers. It is known that ER is differentially bound to DNA leading to transcriptomic and phenotypic changes in different breast cancer models. We investigated whether single nucleotide variants (SNVs) in ER binding sites (regSNVs) contribute to ER action through changes in the ER cistrome,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
